Smartphone problem-solving therapy to reduce fear of cancer recurrence among breast cancer survivors: an open single-arm pilot study
Our study suggests good feasibility and preliminary effectiveness for smartphone problem-solving therapy to reduce fear of recurrence. However, the efficacy needs to be confirmed in a randomized controlled trial. Abstract Objectives The purpose of this study was to investigate a newly developed smar...
Gespeichert in:
Veröffentlicht in: | Japanese journal of clinical oncology 2019-06, Vol.49 (6), p.537-544 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Our study suggests good feasibility and preliminary effectiveness for smartphone problem-solving therapy to reduce fear of recurrence. However, the efficacy needs to be confirmed in a randomized controlled trial.
Abstract
Objectives
The purpose of this study was to investigate a newly developed smartphone problem-solving therapy (PST) application’s feasibility and preliminary effectiveness for reducing fear of cancer recurrence (FCR) among breast cancer survivors.
Methods
Female disease-free breast cancer survivors aged 20–49 years who were more than 6 months post-breast surgery participated in the study. The patients received the smartphone PST using an iPhone or iPad for 8 weeks. The feasibility of the intervention program was evaluated using the overall participation rate, the percentage of survivors who expressed interest in the intervention, and the percentage of completion of the study. Patients were also asked to complete the Concern About Recurrence Scale (CARS) as a primary outcome at baseline, 4 weeks and 8 weeks.
Results
A total of 38 patients participated in this study. The overall participation and completion rates in the study were 47.1% and 97.4%, respectively. The overall fear assessed by CARS was significantly reduced at 8 weeks compared with baseline. A pairwise comparison showed a significant decrease from 4 weeks to 8 weeks and from baseline to 8 weeks.
Conclusions
Smartphone PST, a novel brief intervention to reduce FCR, was well accepted by breast cancer survivors and yielded a favorable effect on FCR. The efficacy of this newly developed smartphone PST needs to be confirmed in a future well-designed randomized controlled trial. |
---|---|
ISSN: | 1465-3621 1465-3621 |
DOI: | 10.1093/jjco/hyz005 |